Keyphrases
Lymphoid Tissue
100%
Agonistic
100%
Chikungunya Virus Infection
100%
Anti-CD137
100%
Chikungunya Virus (CHIKV)
72%
Monoclonal Antibody
45%
Therapeutic Monoclonal Antibody
45%
Virus RNA
36%
T Cells
27%
Musculoskeletal Tissue
27%
Follicular Dendritic Cell
27%
Natural Killer Cells
18%
Germinal Center B Cells
18%
Alphavirus
18%
Dendritic Cells
9%
Tumor
9%
Immune Response
9%
Adaptive Immune Response
9%
B Cells
9%
Costimulatory Molecules
9%
TNF Receptor 1 (TNFR1)
9%
Lymph Node
9%
Cell Response
9%
Cancer Clinical Trials
9%
Surface Proteins
9%
Spleen
9%
Therapeutic Effect
9%
Age of Infection
9%
Viral Tropism
9%
Infectious Reservoir
9%
Human Cancer
9%
T-cell Mediated
9%
Tumor Clearance
9%
Viral Clearance
9%
Splenic B Cells
9%
Persistent Infection
9%
Mouse Infection
9%
Virus Persistence
9%
Arthritogenic alphavirus
9%
Mayaro Virus
9%
CD137
9%
Alphavirus Infection
9%
Chronic Viral Infection
9%
B Cell Subsets
9%
Cellular Reservoirs
9%
Chronic Polyarthritis
9%
Immunology and Microbiology
Viral Disease
100%
Lymphoid Tissue
100%
Chikungunya Virus
100%
Monoclonal Antibody
72%
T Cell
36%
Alphavirus
36%
RNA Virus
36%
B Cell
27%
Follicular Dendritic Cells
27%
Monoclonal Antibody Therapy
18%
Germinal Center
18%
Natural Killer Cell
9%
Dendritic Cell
9%
Immune Response
9%
Lymph Node
9%
Target Cell
9%
Adaptive Immune System
9%
Cell Surface
9%
Inflammatory Arthritis
9%
Viral Clearance
9%
Tumor Necrosis Factor Receptor
9%
Viral Tropism
9%
Natural Killer Cell Response
9%
Splenic B Cell
9%
Mayaro Virus
9%
B Lymphocyte Subpopulation
9%